Drug Discovery Services Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Integration of Artificial Intelligence (AI) in Drug Discovery Services
   3. Market Restraints
      1. Growing Regulatory Stringency
      2. Increasing Costs of Drug Development
   4. Market Opportunities
      1. Growing Demand for Specialized Services Targeting the Intricacies of Rare and Orphan Diseases
   5. Market Trends
      1. Biomarker-Driven Drug Discovery
      2. Expansion of Antiviral Drug Discovery Services
5. MARKET SEGMENTATION
   1. By Process
      1. Target Selection
      2. Target Validation
      3. Hit-to-Lead Identification
      4. Lead Optimization
      5. Candidate Validation
   2. By Type
      1. Chemistry Services
      2. Biology Services
   3. By Drug Type
      1. Small-molecule Drugs
      2. Biologics
   4. By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurological Diseases
      4. Immunological Diseases
      5. Endocrine and Metabolic Diseases
      6. Respiratory Diseases
      7. Digestive System Diseases
      8. Cardiovascular Diseases
      9. Genitourinary Diseases
      10. Other Therapeutic Area ( Dermatology, Ophthalmology, Rare and Orphan Diseases)
   5. By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Academic Institutes
      3. Other End Users (Small CROs, IVD companies, and Clinical Laboratories)
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. AbbVie Inc.
      2. Abbott Laboratories
      3. Charles River Laboratories International Inc.
      4. Frontage Holdings
      5. Johnson & Johnson
      6. Laboratory Corporation of America Holdings
      7. Pfizer Inc.
      8. Thermo Fisher Scientific

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global drug discovery services market?

The global market of drug discovery services is projected to reach USD 53.66 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global drug discovery services market?

The global drug discovery services market has an estimated annual growth rate of 10.1% .

Q.3. What are the recent trends of drug discovery services market?

Biomarker-driven drug discovery and expansion of antiviral drug discovery servicesare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in drug discovery services?

The major companies profiled in this report include AbbVie Inc., Abbott Laboratories , Charles River Laboratories International Inc., Frontage Holdings, Johnson & Johnson, Laboratory Corporation of America Holdings, Pfizer Inc., Thermo Fisher Scientific, among others.

Q.5. Which region is estimated to held highest CAGR indrug discovery services market?

North America is estimated to hold biggest share in the market for drug discovery services.